Cuvitru

Cuvitru is a subcutaneous immunoglobulin therapy designed to support immune function. This medication is commonly used for conditions related to immune system deficiencies.

Cuvitru is primarily used to treat primary immune deficiencies, where the body's immune system does not function properly. It works by providing antibodies to help prevent infections. This therapy is administered subcutaneously, making it a convenient option for long-term immune support.

Common effects of Cuvitru may include mild reactions at the injection site, such as redness or swelling. Some individuals might experience temporary discomfort or itching. These effects are generally mild and short-lived.

Cuvitru should be used under medical supervision. It is important to inform your healthcare provider about any allergies or existing medical conditions before starting this therapy. Always follow the prescribed administration guidelines to minimize risks.

Cuvitru may interact with certain medications, particularly those that affect the immune system. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and other substances should be considered as well.